HuP-T3
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
HuP-T3 is a human pancreatic carcinoma cell line derived from the ascites of pancreatic cancer patients suffering from carcinomatous peritonitis. These cells exhibit an epithelial morphology when grown in monolayer cultures and possess a population doubling time of approximately 38.6 hours. HuP-T3 cells produce a limited amount of CEA (carcinoembryonic antigen) and display tumorigenicity when transplanted into nude mice, resulting in the formation of poorly differentiated adenocarcinomas. For subculturing purposes, the cells are split at a ratio of 1:4 to 1:10 using trypsin/EDTA for approximately 10-15 minutes.
Why choose HuP-T3 from AcceGen?
HuP-T3 cells from AcceGen offer exceptional quality and viability, characterized by sterility, mycoplasma negativity verified through PCR-based testing, and the absence of various viruses including EBV, HBV, HCV, HHV-8, HIV-1, HIV-2, HTLV-1/2, and MLV. Their identity is confirmed using STR analysis, and they are cultivated under optimal conditions with stringent quality control measures in place to ensure reliability and consistency.
| Product Code | HUP-T3; Hu-P-T3; HuPT3; HupT3; HUPT3 |
| Species | Human |
| Cat.No | ABC-TC497S |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Pancreas |
| Storage | Liquid Nitrogen |
| Product Type | Human Pancreas Cancer Cell Lines |
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
FOR RESEARCH USE ONLY
The HuP-T3 cell line serves as a valuable model for elucidating the intricate biological and biochemical features of pancreatic cancer. It offers a platform to explore and uncover critical factors and the underlying mechanisms that drive invasion and migration in pancreatic cancer. By studying HuP-T3 cells, researchers can gain insights into the molecular pathways and processes involved in the aggressive nature of this disease, ultimately contributing to a deeper understanding of pancreatic cancer and the development of potential therapeutic strategies to combat its progression.
